Vanda Pharmaceuticals Inc (VNDA) — Working Capital to Net Assets Ratio
Vanda Pharmaceuticals Inc (VNDA) has a Working Capital to Net Assets ratio of 61.8% as of December 2025. Working capital of $202.10 Million (current assets of $347.26 Million minus current liabilities of $145.16 Million) is measured against net assets of $327.19 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Vanda Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Vanda Pharmaceuticals Inc Working Capital to Net Assets (2004–2025)
This chart shows how Vanda Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 61.8%, reflecting working capital of $202.10 Million against net assets of $327.19 Million USD. For the complete balance sheet picture, see balance sheet size of Vanda Pharmaceuticals Inc.
Annual Working Capital to Net Assets for Vanda Pharmaceuticals Inc (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Vanda Pharmaceuticals Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Vanda Pharmaceuticals Inc's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 61.8% | $202.10 Million | $327.19 Million | $347.26 Million | $145.16 Million | ▼ -1.2 pp |
| 2024 | 62.9% | $338.91 Million | $538.55 Million | $438.89 Million | $99.98 Million | ▼ -0.4 pp |
| 2023 | 63.4% | $345.25 Million | $544.91 Million | $432.95 Million | $87.70 Million | ▼ -17.8 pp |
| 2022 | 81.2% | $427.86 Million | $527.20 Million | $519.29 Million | $91.44 Million | ▲ +1.2 pp |
| 2021 | 80.0% | $403.88 Million | $504.93 Million | $478.30 Million | $74.42 Million | ▲ +4.3 pp |
| 2020 | 75.7% | $343.21 Million | $453.27 Million | $409.14 Million | $65.94 Million | ▲ +4.0 pp |
| 2019 | 71.7% | $294.63 Million | $410.94 Million | $354.14 Million | $59.51 Million | ▼ -17.7 pp |
| 2018 | 89.4% | $246.12 Million | $275.42 Million | $299.13 Million | $53.02 Million | ▲ +13.6 pp |
| 2017 | 75.7% | $99.49 Million | $131.39 Million | $169.86 Million | $70.36 Million | ▼ -18.6 pp |
| 2016 | 94.3% | $123.86 Million | $131.33 Million | $174.18 Million | $50.32 Million | ▲ +7.7 pp |
| 2015 | 86.6% | $115.23 Million | $133.03 Million | $166.55 Million | $51.32 Million | ▲ +3.3 pp |
| 2014 | 83.3% | $133.94 Million | $160.82 Million | $141.73 Million | $7.79 Million | ▼ -149.6 pp |
| 2013 | 232.9% | $102.76 Million | $44.12 Million | $135.61 Million | $32.85 Million | ▼ -713.1 pp |
| 2012 | 946.0% | $93.70 Million | $9.90 Million | $125.97 Million | $32.26 Million | ▲ +581.9 pp |
| 2011 | 364.1% | $121.88 Million | $33.47 Million | $153.50 Million | $31.62 Million | ▼ -89.6 pp |
| 2010 | 453.7% | $171.18 Million | $37.73 Million | $202.21 Million | $31.03 Million | ▼ -334.0 pp |
| 2009 | 787.7% | $181.42 Million | $23.03 Million | $212.95 Million | $31.53 Million | ▲ +691.4 pp |
| 2008 | 96.3% | $44.33 Million | $46.02 Million | $47.75 Million | $3.41 Million | ▲ +7.7 pp |
| 2007 | 88.6% | $74.18 Million | $83.73 Million | $86.96 Million | $12.78 Million | ▼ -3.8 pp |
| 2006 | 92.4% | $24.71 Million | $26.76 Million | $33.82 Million | $9.11 Million | ▲ +0.1 pp |
| 2005 | 92.3% | $28.31 Million | $30.66 Million | $33.37 Million | $5.06 Million | ▼ -0.7 pp |
| 2004 | 93.0% | $14.83 Million | $15.94 Million | $16.45 Million | $1.62 Million | — |